Coordinated Recovery Initiative for Babies Act of 2014 or the CRIB Act of 2014 - Directs the Secretary of Health and Human Services (HHS) to study the treatment and surveillance of, and available information concerning, neonatal abstinence syndrome (a group of problems occurring in a newborn who was exposed to addictive drugs while in the mother's womb).
Requires the Secretary to establish an advisory panel to identify and compile best practices and to disseminate the practices, including through the public HHS website. Requires a review of the best practices at least every two years.
[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4888 Introduced in House (IH)]
113th CONGRESS
2d Session
H. R. 4888
To provide for the identification and dissemination of best practices
for medical professionals and other health care providers relative to
neonatal abstinence syndrome, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 18, 2014
Ms. Clark of Massachusetts (for herself and Mr. Stivers) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for the identification and dissemination of best practices
for medical professionals and other health care providers relative to
neonatal abstinence syndrome, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Coordinated Recovery Initiative for
Babies Act of 2014'' or the ``CRIB Act of 2014''.
SEC. 2. IDENTIFICATION, TREATMENT, AND SURVEILLANCE OF NEONATAL
ABSTINENCE SYNDROME.
(a) Study.--The Secretary of Health and Human Services (in this Act
referred to as the ``Secretary'') shall conduct a study to identify--
(1) the most effective and beneficial methods that are
currently available to identify the need for treating and best
treatment methods for, infants diagnosed with neonatal
abstinence syndrome;
(2) barriers, including associated costs and limitations or
disparities in the availability or scope of health insurance
coverage, that may hinder the clinical use of best practices by
medical professionals and other health care providers for the
identification and treatment of neonatal abstinence syndrome;
(3) circumstances, such as populations with unique needs
and health care settings with limited resources, that may
require particularized best practices for medical professionals
and other health care providers for the identification and
treatment of neonatal abstinence syndrome;
(4) existing surveillance measures within the Department of
Health and Human Services (in this Act referred to as the
``Department'') and in State health agencies relating to
neonatal abstinence syndrome; and
(5) areas in which information on neonatal abstinence
syndrome and its surrounding circumstances is insufficient,
incomplete, or requires further study or analysis.
(b) Advisory Panel.--
(1) Establishment.--The Secretary shall convene an advisory
panel (in this section referred to as the ``Panel'') to
identify and compile the best practices under subsection (c).
The Secretary shall reconvene the Panel for such purpose
whenever the Secretary, with the advice of the Panel,
determines updates are needed to the list of best practices
under subsection (e), but no less than every 2 years.
(2) Members.--The Panel shall be composed of 19 members,
all of whom shall be medical professionals or health care
providers with expertise in neonatal abstinence syndrome.
Members shall represent the broad range of such professionals
and providers necessary to identify and compile the best
practices for identification and treatment of neonatal
abstinence syndrome, including representatives of--
(A) The American Academy of Family Physicians.
(B) The American Academy of Pediatrics.
(C) The American Academy of Physician Assistants.
(D) The American College of Nurse-Midwives.
(E) The American College of Obstetricians and
Gynecologists.
(F) The American Hospital Association.
(G) The American Medical Association.
(H) The American Nurses Association.
(I) The American Pharmacists Association.
(J) The American Public Health Association.
(K) The American Society for Addiction Medicine.
(L) The American Society of Anesthesiologists.
(M) The Association of State and Territorial Health
Professionals.
(N) The Association of Women's Health, Obstetric,
and Neonatal Nurses.
(O) The Children's Hospital Association.
(P) The National Association of Medicaid Directors.
(Q) The National Association of Nurse Practitioners
in Women's Health.
(R) The National Association of Pediatric Nurse
Practitioners.
(S) The National Association of Social Workers.
(3) Administrative support.--The Secretary shall provide
appropriate administrative support, including technical
assistance, to the Panel.
(c) Best Practices; Plan; Report.--Not later than 12 months after
the date of enactment of this Act, the Secretary shall--
(1)(A) identify and compile the best practices for medical
professionals and other health care providers for identifying
and treating neonatal abstinence syndrome; and
(B) identify any gaps in best practices for medical
professionals and other health care providers that may require
additional research or analysis;
(2) develop and implement a plan for the coordination and,
if necessary, expansion and enhancement of public health
surveillance of neonatal abstinence syndrome that--
(A) identifies the data necessary for a public
health response to neonatal abstinence syndrome;
(B) identifies any gaps in current surveillance or
coordination that results in the lack of collection of
such data, including a lack of timeliness or
standardization of data reporting;
(C) makes recommendations and provides assistance
to the States to implement effective measures to
collect such necessary data by State health agencies;
and
(D) designates an appropriate agency in the
Department to coordinate such data; and
(3) not later than 18 months after the date of enactment of
this Act, submit to the Congress a report containing the
Secretary's findings and identifying issues that--
(A) relate to neonatal abstinence syndrome,
including its causes, identification, treatment,
prevalence, and effects; and
(B) public health issues related to neonatal
abstinence syndrome that would benefit from further
study.
(d) Dissemination of Best Practices.--The Secretary--
(1) shall disseminate the best practices identified and
compiled under subsection (c), including any updates under
subsection (e), directly or through arrangements with nonprofit
organizations, government agencies, or the media;
(2) shall post such best practices on the public Internet
site of the Department; and
(3) may include in such dissemination any supplemental
information which the Secretary determines to be relevant and
appropriate, in consultation with the Panel.
(e) Updates to Best Practices.--The Secretary shall periodically,
but no less often than every 2 years, review the best practices
identified under subsection (c) to ensure that such best practices are
up-to-date and reflect the views of the medical community, including
organizations listed in subsection (b)(2).
(f) Appropriate Agency.--In designating an appropriate agency
within the Department under subsection (c), the Secretary shall
consider, among other factors, agency resources, purpose, expertise,
and capability to conduct public health programs and research.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Sponsor introductory remarks on measure. (CR H5882)
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line